Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 5, 2002, Pages 913-918

  Obinu, Maria Carmen ^a   Reibaud, Michel ^a   Miquet, Jean Marie ^a   Pasquet, Martine ^a   Rooney, Thomas ^a  

^a SANOFI   (France)

Author keywords

ACh release; Mice; Microdialysis; Nicotinic agonist; Object recognition test; Rats; TC 1734

Indexed keywords

ACETYLCHOLINE; ISPRONICLINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; FRONTAL CORTEX; MALE; MEMORY; MICRODIALYSIS; MOUSE; NONHUMAN; PARIETAL LOBE; RAT; RECOGNITION; SEIZURE; TRAINING;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; BRAIN; CEREBRAL CORTEX; DRUG ADMINISTRATION SCHEDULE; FRONTAL LOBE; MALE; MEMORY; MICE; NICOTINIC AGONISTS; PARIETAL LOBE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION;

EID: 0036592436     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00205-1     Document Type: Article

References (37)

1. 3H] nicotine binding sites. Synapse. 21:1995;281-288.
2. Abdulla F.A., Bradbury E., Calaminici M.R., Lippiello P.M., Wonnacott S., Gray J.A., Sinden J.D. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology. 124:1995;323-331.
3. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J. Neurochem. 51:1988;292-299.
4. 3H-acetylcholine release from cortical slices of guinea-pig brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 331:1985;293-296.
5. Benowitz N.L. Clinical pharmacology of nicotine. Annu. Rev. Med. 37:1986;21-32.
6. Bontempi B., Whelan K.T., Risbrough V.B., Rao T.S., Buccafusco J.J., Lloyd G.K., Menzaghi F. SIB-(+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thiol]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J. Pharmacol. Exp. Ther. 299:2001;297-306.
7. Buccafusco J.J., Jackson W.J. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol. Aging. 12:1991;233-238.
8. Clarke P.B.S. Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation. Prog. Brain Res. 98:1993;77-82.
9. Cregan E., Ordy J.M., Palmer E., Blosser J., Wengenak T., Thomas G. Spatial working memory enhancement by nicotine of aged Long Evans rats in the T-maze. Soc. Neurosci. Abstr. 15:1989;731. Part 1.
10. Damsma G., Westerink B.H.C. A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivo. Robinson T.E., Justice J.B. Microdialysis in the Neuroscience. 1991;237-252 Elsevier, Amsterdam.
11. Decker M.W., Majchrzak M.J. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology. 107:1992;530-534.
12. Decker M.W., Brioni J.D., Sullivan J.P., Buckley M.J., Radek R.J., Raszkiewicz J.L., Kang C.H., Kim D.J.B., Giardina W.J., Wasicak J.T., Garvey D.S., Williams A., Arneric S.P. (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT418): a novel cholinergic ligand with cognition- enhancing and anxiolytic activities: II. In vivo characterization. J. Pharmacol. Exp. Ther. 270:1994;319-328.
13. De Sarno P., Giacobini E. Modulation of acetylcholine release by nicotinic receptors in the rat brain. J. Neurosci. Res. 22:1989;194-200.
14. Dodart J.C., Manthis C., Ungerer A. Scopolamine-induced deficits in a two-trial object recognition task in mice. NeuroReport. 8:1997;1173-1178.
15. Gatto G.J., Lippiello P.M., Caldwell W.S., Bencherif M. Reversal of scopolamine-induced deficits in the passive avoidance task by Targacept (TI) nicotinic agonists alone and in combination with tacrine and donepezil. Soc. Neurosci. Abstr. 25:1999;1982. Part 2.
16. Imperato A., Angelucci L., Zocchi A., Casolini P., Puglisi-Allegra S. Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res. 577:1992;194-199.
17. Jones G.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention information processing short-term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
18. Levin E.D. Nicotinic system and cognitive function. Psychopharmacology. 108:1992;417-431.
19. Lippiello P.M., Bencherif M., Gray J.A., Peters S., Grigoryan G., Hodges H., Collins A.C. RJR-2403: a nicotinic agonist with CNS selectivity: II. In vivo characterization. J. Pharmacol. Exp. Ther. 279:1996;1422-1429.
20. Lippiello P.M., Gatto G.J., Bencherif M., Fowler K.W., Caldwell W.S. RJR 1734: a potent selective nicotinic ligand that improves cognition acutely and chronically. Soc. Neurosci. Abstr. 24:1998;88. Part 1.
21. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of «impaired» cholinergic presynaptic function. J. Neurochem. 67:1996;1974-1981.
22. 2+ ions in their function and desensitization. Neurochem. Int. 34:1999;319-328.
23. Menzaghi F., Joppa M.A., Reid R.T., Sacaan A.I., Bontempi B., Whelan K.T., Santori E.M., Risbrough V.B., Lloyd G.K. Memory deficits associated with cholinergic dysfunctions: reversal by SIB-1553A, a novel nAChR agonist. Soc. Neurosci. Abstr. 23:1997;1200. Part 2.
24. Menzaghi F., McClure D.E., Lloyd G.K. Subtype-selective nAChR agonists for the treatment of neurological disorders: SIB 1508Y and SIB-1553A. Arneric S.P. Neuronal Nicotinic Receptors. Pharmacology and Therapeutic Opportunities. 1998;379-394 Wiley-Liss, New York.
25. Newhouse P.A., Sunderlag T., Thompson K., Tariot P.N., Weingartner H., Mueller E.R., Cohen R.M., Murphy D.L. Intravenous nicotine in a patient with Alzheimer's disease. Am. J. Psychiatry. 143:1986;1494-1495.
26. Newhouse P.A., Potter A., Corwin J., Lenox R. Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology. 108:1992;480-484.
27. Newhouse P.A., Potter A., Corwin J., Lenox R. Age-related effects of nicotine antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology. 10:1994;93-107.
28. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, New York. Fig. 14.
29. Quirion E., Richard J., Wilson A. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats. Synapse. 17:1994;92-100.
30. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43:1984;1593-1598.
31. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effect of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry. 154:1989;797-800.
32. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
33. Schneider J.S., Tinker J.P., Van Velson M., Menzaghi F., Lloyd K. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys. J. Pharmacol. Exp. Ther. 290:1999;731-739.
34. Summers K.L., Giacobini E. Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem. Res. 20:1995;753-759.
35. Summers K.L., Cuadra G., Naritoku D., Giacobini E. Effects of nicotine on levels of acetylcholine and biogenic amines in rat cortex. Drug Dev. Res. 31:1994;108-119.
36. Summers K.L., Lippiello P., Giacobini E. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines. Neurochem. Res. 21:1996;1181-1186.
37. Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G.G. Presynaptic modulation of transmitter release by nicotinic receptors. Prog. Brain. Res. 79:1989;157-163.